跳至主要内容
临床试验/PACTR202403689052671
PACTR202403689052671已完成2 期

Comparative study of morphine, fentanyl or nalbuphine patient controlled analgesia for mucositis pain in pediatric patients undergoing cancer therapy: A randomized clinical trial

Childrens Cancer Hospital Egypt 573570 个研究点目标入组 90 人开始时间: 2024年3月4日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • aged 7-18 years
  • admitted to the Children Cancer Hospital Egypt 57357
  • diagnosed with cancer
  • and undergoing cancer therapy complicated by mucositis grade 3 and 4 (severe oral mucositis)

排除标准

  • central nervous system disorders, delayed developmental milestones, or mental retardation that might interfere with the assessment of pain intensity
  • known or suspected myopathy
  • known or suspected allergy to any narcotic
  • known history of intolerable side effects of opioids
  • renal impairment (creatinine clearance less than 50 mL/min)
  • hepatic dysfunction (liver enzymes elevated more than 10-fold)
  • respiratory distress (SPO2 less than 92% on room air)
  • cardiac disease (ejection fraction less than 40%)
  • chronic pain complaints
  • advanced or metastatic cancer scheduled for palliative care

研究者

发起方
Childrens Cancer Hospital Egypt 57357

相似试验